Web30 mar 2024 · In recent years, multidisciplinary treatment, including chemotherapy, radiotherapy, and surgery, has been used for esophageal cancer. The JCOG9204 study conducted in Japan (1992–1997) compared the outcomes of surgery alone with the outcomes of surgery plus postoperative chemotherapy with CF . WebAndo N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study – JCOG9204. J Clin Oncol, 21: 4592–4596, 2003. …
Postoperative Chemotherapy for Thoracic Pathological T3N0M0 …
Web29 giu 2024 · The regimen of JCOG9204 was cisplatin and fluorouracil, but the treatment applied to patients was complicated due to individual discrepancies after recurrence. Some study results have supported the JCOG9204 conclusion and indicated that patients with stage III–IV disease can obtain a long-term survival benefit from postoperative … WebAffiliations 1 Japan Clinical Oncology Group (JCOG) Data Centre/Operations Office, Centre for Research Administration and Support, National Cancer Centre, Tokyo, Japan.; 2 Oesophageal Surgery Division, National Cancer Centre Hospital, Tokyo, Japan.; 3 Department of Gastrointestinal Surgery, Tokai University School of Medicine, Isehara, … city of dallas building permit application
The impact of adjuvant therapy on survival for node-negative …
Web20 mag 2014 · Methods: Two phase III trials for cStage II or III esophageal cancer, JCOG9204 (accrual period: 1992-1997, Ando N, JCO 2003) and JCOG9907 (2000 … WebBackground: Patients with esophageal carcinoma receiving postoperative chemotherapy showed superior disease-free survival than those receiving surgery alone in a Japan … Web20 mag 2008 · 4510. Background: The phase III trial (JCOG9204) comparing postoperative adjuvant chemotherapy using cisplatin plus 5- fluorouracil (5-FU) with surgery alone … do nj maternity laws apply to all employees